The messenger market is presently experiencing significant growth, fueled by the successful deployment of mRNA-based medications against COVID-19. Research suggest a complex landscape, with ongoing investments into therapeutic applications separate from infectious diseases, including areas such as oncology, rare diseases, and protein replacement ca